Flow Traders U.S.’s Apexigen, Inc. WarrantApexigen, Inc. Warrant APGNW Stock Holding History

Flow Traders U.S.’s Portfolio APGNW Stock Details APGNW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-14,053	Closed	–	–	1268
2023 Q2	$0	Sell	14,053 -6,487	-32%	-$283	﹤0.01%	1200
2023 Q1	$1K	Buy	20,540 +2,386	+13%	+$202	﹤0.01%	891
2022 Q4	$0	Buy	+18,154	New	+$1.45K	﹤0.01%	1236

Other funds holding APGNW

RCM

Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return

Flow Traders U.S.'s APGNW Position: Q3 2023 in Review

Flow Traders U.S. sold out of Apexigen, Inc. WarrantApexigen, Inc. Warrant (APGNW) in Q3 2023, closing a stake of 14,053 shares.

Flow Traders U.S. first reported a position in APGNW in Q4 2022 and held it in 3 quarters. The position peaked at $1K in Q1 2023. 1 fund tracked by Wall St. Rank holds APGNW as of Q3 2023.

Flow Traders U.S. reported no remaining Apexigen, Inc. WarrantApexigen, Inc. Warrant position as of Q3 2023 after selling out during the quarter.
Flow Traders U.S. sold 14,053 Apexigen, Inc. WarrantApexigen, Inc. Warrant shares in Q3 2023.
Flow Traders U.S. first reported a position in Apexigen, Inc. WarrantApexigen, Inc. Warrant in Q4 2022 and held it in 3 quarters.
Flow Traders U.S.'s Apexigen, Inc. WarrantApexigen, Inc. Warrant position peaked at $1K in Q1 2023.
1 fund tracked by Wall St. Rank held Apexigen, Inc. WarrantApexigen, Inc. Warrant as of Q3 2023.

Based on Flow Traders U.S.'s 13F filing for Q3 2023, filed 14 Nov 2023.